These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 23449793)

  • 21. Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.
    Ching JC; Chan KY; Lee EH; Xu MS; Ting CK; So TM; Sham PC; Leung GM; Peiris JS; Khoo US
    J Infect Dis; 2010 Jun; 201(12):1899-908. PubMed ID: 20462354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.
    Gierer S; Bertram S; Kaup F; Wrensch F; Heurich A; Krämer-Kühl A; Welsch K; Winkler M; Meyer B; Drosten C; Dittmer U; von Hahn T; Simmons G; Hofmann H; Pöhlmann S
    J Virol; 2013 May; 87(10):5502-11. PubMed ID: 23468491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.
    Channappanavar R; Fehr AR; Vijay R; Mack M; Zhao J; Meyerholz DK; Perlman S
    Cell Host Microbe; 2016 Feb; 19(2):181-93. PubMed ID: 26867177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.
    Lui PY; Wong LY; Fung CL; Siu KL; Yeung ML; Yuen KS; Chan CP; Woo PC; Yuen KY; Jin DY
    Emerg Microbes Infect; 2016 Apr; 5(4):e39. PubMed ID: 27094905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of severe acute respiratory syndrome.
    Lau YL; Peiris JS
    Curr Opin Immunol; 2005 Aug; 17(4):404-10. PubMed ID: 15950449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exacerbated innate host response to SARS-CoV in aged non-human primates.
    Smits SL; de Lang A; van den Brand JM; Leijten LM; van IJcken WF; Eijkemans MJ; van Amerongen G; Kuiken T; Andeweg AC; Osterhaus AD; Haagmans BL
    PLoS Pathog; 2010 Feb; 6(2):e1000756. PubMed ID: 20140198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
    Hu Y; Li W; Gao T; Cui Y; Jin Y; Li P; Ma Q; Liu X; Cao C
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.
    Spiegel M; Pichlmair A; Martínez-Sobrido L; Cros J; García-Sastre A; Haller O; Weber F
    J Virol; 2005 Feb; 79(4):2079-86. PubMed ID: 15681410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad Cross-Species Infection of Cultured Cells by Bat HKU2-Related Swine Acute Diarrhea Syndrome Coronavirus and Identification of Its Replication in Murine Dendritic Cells
    Yang YL; Qin P; Wang B; Liu Y; Xu GH; Peng L; Zhou J; Zhu SJ; Huang YW
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist.
    Niemeyer D; Zillinger T; Muth D; Zielecki F; Horvath G; Suliman T; Barchet W; Weber F; Drosten C; Müller MA
    J Virol; 2013 Nov; 87(22):12489-95. PubMed ID: 24027320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.
    Kumaki Y; Day CW; Bailey KW; Wandersee MK; Wong MH; Madsen JR; Madsen JS; Nelson NM; Hoopes JD; Woolcott JD; McLean TZ; Blatt LM; Salazar AM; Smee DF; Barnard DL
    Antivir Chem Chemother; 2010 Mar; 20(4):169-77. PubMed ID: 20231782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.
    van Boheemen S; de Graaf M; Lauber C; Bestebroer TM; Raj VS; Zaki AM; Osterhaus AD; Haagmans BL; Gorbalenya AE; Snijder EJ; Fouchier RA
    mBio; 2012 Nov; 3(6):. PubMed ID: 23170002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.
    Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A
    Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests.
    Chan KH; Chan JF; Tse H; Chen H; Lau CC; Cai JP; Tsang AK; Xiao X; To KK; Lau SK; Woo PC; Zheng BJ; Wang M; Yuen KY
    J Infect; 2013 Aug; 67(2):130-40. PubMed ID: 23583636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.